Home LiteratureArticle Details
PMID: 10644367 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Journal of virology ·Vol. 74 ·No. 4 ·2000-02-00 ·Pages 1939-47

Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD

Abstract

EBNA2 is essential for Epstein-Barr virus (EBV) immortalization of B lymphocytes. EBNA2 functions as a transcriptional activator and targets responsive promoters through interaction with the cellular DNA binding protein CBF1. We have examined the mechanism whereby EBNA2 overcomes CBF1-mediated transcriptional repression. A yeast two-hybrid screen performed using CBF1 as the bait identified a protein, SKIP, which had not previously been recognized as a CBF1-associated protein. Protein-protein interaction assays demonstrated contacts between SKIP and the SMRT, CIR, Sin3A, and HDAC2 proteins of the CBF1 corepressor complex. Interestingly, EBNA2 also interacted with SKIP in glutathione S-transferase affinity and mammalian two-hybrid assays and colocalized with SKIP in immunofluorescence assays. Interaction with SKIP was not affected by mutation of EBNA2 conserved region 6, the CBF1 interaction region, but was abolished by mutation of conserved region 5. Mutation of conserved region 5 also severely impaired EBNA2 activation of a reporter containing CBF1 binding sites. Thus, interaction with both CBF1 and SKIP is necessary for efficient promoter activation by EBNA2. A model is presented in which EBNA2 competes with the SMRT-corepressor complex for contacts on SKIP and CBF1.

MeSH Terms
Amino Acid Sequence Binding Sites Cell Line, Transformed DNA-Binding Proteins/genetics,metabolism Epstein-Barr Virus Nuclear Antigens Gene Expression Regulation HeLa Cells Histone Deacetylase 2 Histone Deacetylases/metabolism Humans Immunoglobulin J Recombination Signal Sequence-Binding Protein Molecular Sequence Data Nuclear Proteins/genetics,metabolism,physiology Nuclear Receptor Co-Repressor 2 Nuclear Receptor Coactivators Promoter Regions, Genetic Recombinant Fusion Proteins/genetics,metabolism Repressor Proteins/metabolism Sin3 Histone Deacetylase and Corepressor Complex Transcription Factors Transfection Viral Proteins/genetics,metabolism
Chemicals
CIR1 protein, human DNA-Binding Proteins EBNA-2 protein, Human herpesvirus 4 Epstein-Barr Virus Nuclear Antigens Immunoglobulin J Recombination Signal Sequence-Binding Protein NCOR2 protein, human Nuclear Proteins Nuclear Receptor Co-Repressor 2 Nuclear Receptor Coactivators RBPJ protein, human Recombinant Fusion Proteins Repressor Proteins SIN3A transcription factor SNW1 protein, human Transcription Factors Viral Proteins Histone Deacetylase 2 Histone Deacetylases Sin3 Histone Deacetylase and Corepressor Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Zhou S
Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.
Fujimuro M
Hsieh J J
Chen L
Hayward S D
References (62)
62 references, click to expand
  1. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.
    J Biol Chem. 1997 Oct 31;272(44):28001-7 PMID: 9346952
  2. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
    EMBO J. 1994 Jul 15;13(14):3321-8 PMID: 8045261
  3. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    J Virol. 1995 Jan;69(1):253-62 PMID: 7983717
  4. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.
    J Virol. 1995 Jan;69(1):585-8 PMID: 7983760
  5. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    EMBO J. 1994 Dec 1;13(23):5624-32 PMID: 7988559
  6. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
    EMBO J. 1994 Dec 1;13(23):5633-8 PMID: 7988560
  7. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.
    EMBO J. 1995 Jan 3;14(1):88-96 PMID: 7828599
  8. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk.
    J Virol. 1995 Mar;69(3):1944-50 PMID: 7853539
  9. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72 PMID: 8052621
  10. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    J Virol. 1994 Sep;68(9):5375-83 PMID: 8057421
  11. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    J Virol. 1994 Nov;68(11):6947-58 PMID: 7933076
  12. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Virology. 1994 Nov 1;204(2):634-41 PMID: 7941331
  13. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    J Virol. 1996 Sep;70(9):6020-8 PMID: 8709224
  14. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H).
    Curr Biol. 1995 Dec 1;5(12):1416-23 PMID: 8749394
  15. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.
    J Virol. 1997 Mar;71(3):1938-45 PMID: 9032325
  16. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression.
    Nature. 1997 May 1;387(6628):43-8 PMID: 9139820
  17. Histone deacetylase activity is required for full transcriptional repression by mSin3A.
    Cell. 1997 May 2;89(3):341-7 PMID: 9150133
  18. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
    Cell. 1997 May 2;89(3):349-56 PMID: 9150134
  19. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.
    Cell. 1997 May 2;89(3):373-80 PMID: 9150137
  20. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3259-63 PMID: 7724549
  21. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
    Science. 1995 Apr 28;268(5210):560-3 PMID: 7725102
  22. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.
    Mol Cell Biol. 1995 Sep;15(9):4735-44 PMID: 7651391
  23. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.
    Mol Cell Biol. 1995 Nov;15(11):6150-9 PMID: 7565767
  24. Signalling downstream of activated mammalian Notch.
    Nature. 1995 Sep 28;377(6547):355-8 PMID: 7566092
  25. RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.
    Nucleic Acids Res. 1995 Dec 25;23(24):4939-45 PMID: 8559649
  26. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
    Mol Cell Biol. 1996 Mar;16(3):952-9 PMID: 8622698
  27. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
    J Virol. 1996 Apr;70(4):2481-9 PMID: 8642676
  28. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes.
    J Virol. 1996 Jun;70(6):4179-83 PMID: 8648764
  29. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    J Virol. 1996 Jul;70(7):4228-36 PMID: 8676443
  30. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    J Virol. 1996 Sep;70(9):5909-15 PMID: 8709211
  31. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
    J Virol. 1997 Dec;71(12):9134-42 PMID: 9371570
  32. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
    J Virol. 1998 Jan;72(1):693-700 PMID: 9420275
  33. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
    J Virol. 1998 Feb;72(2):1365-76 PMID: 9445037
  34. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42.
    Oncogene. 1998 Mar 26;16(12):1579-86 PMID: 9569025
  35. Nuclear access and action of notch in vivo.
    Cell. 1998 May 15;93(4):649-60 PMID: 9604939
  36. Indirect evidence for Delta-dependent intracellular processing of notch in Drosophila embryos.
    Curr Biol. 1998 Jun 18;8(13):771-4 PMID: 9651681
  37. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.
    Genes Dev. 1998 Aug 1;12(15):2269-77 PMID: 9694793
  38. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    J Virol. 1998 Dec;72(12):9948-54 PMID: 9811732
  39. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.
    Nature. 1998 May 28;393(6683):382-6 PMID: 9620803
  40. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.
    J Virol. 1998 Jul;72(7):6034-9 PMID: 9621066
  41. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.
    Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):23-8 PMID: 9874765
  42. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
    Virology. 1998 Dec 20;252(2):418-30 PMID: 9878621
  43. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
    J Virol. 1999 Jan;73(1):826-33 PMID: 9847397
  44. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor.
    Genes Dev. 1999 Feb 15;13(4):412-23 PMID: 10049357
  45. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.
    J Virol. 1999 Apr;73(4):2770-80 PMID: 10074124
  46. The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.
    Biol Chem. 1999 Feb;380(2):213-21 PMID: 10195428
  47. Notch signaling: cell fate control and signal integration in development.
    Science. 1999 Apr 30;284(5415):770-6 PMID: 10221902
  48. Histone deacetylases: transcriptional repression with SINers and NuRDs.
    Trends Cell Biol. 1999 May;9(5):193-8 PMID: 10322454
  49. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus.
    J Virol. 1999 Oct;73(10):8867-72 PMID: 10482645
  50. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    J Virol. 1991 May;65(5):2164-9 PMID: 1850003
  51. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    J Virol. 1991 Aug;65(8):4101-6 PMID: 1649318
  52. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    J Virol. 1991 Nov;65(11):5880-5 PMID: 1656076
  53. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    J Virol. 1991 Dec;65(12):6765-71 PMID: 1658373
  54. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    J Virol. 1992 May;66(5):2846-52 PMID: 1313905
  55. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.
    J Virol. 1992 Sep;66(9):5500-8 PMID: 1323708
  56. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    EMBO J. 1993 Jan;12(1):167-75 PMID: 8381349
  57. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    J Virol. 1993 Jun;67(6):2990-3003 PMID: 8388484
  58. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
  59. Recognition sequence of a highly conserved DNA binding protein RBP-J kappa.
    Nucleic Acids Res. 1994 Mar 25;22(6):965-71 PMID: 8152928
  60. The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor.
    Mol Cell Biol. 1994 May;14(5):3310-9 PMID: 8164682
  61. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Science. 1994 Jul 1;265(5168):92-5 PMID: 8016657
  62. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
    EMBO J. 1994 Oct 17;13(20):4973-82 PMID: 7957063
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-02-00
Pages
1939-47
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC111672
Subset
IM
Grants
NCI NIH HHS · R01 CA042245 · United States
NCI NIH HHS · R01 CA42245 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]